EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Evaluation of Bovine Lactoferrin for Prevention of Late-Onset Sepsis in Low-Birth-Weight Infants: A Double-Blind Randomized Controlled Trial

Shabina Ariff iD, Sajid Bashir Soofi iD, Uswa Jiwani, Almas Aamir, Uzair Ansari, Arjumand Rizvi iD, Michelle D'Almeida, Ashraful Alam iD, Michael Dibley iD

Nutrients · 2025

DOI: 10.3390/nu17111774 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Shabina Ariff und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric and Child Health, Aga Khan University, Karachi 74800, Pakistan. Hauptthemen laut MEDLINE: Lactoferrin, Infant, Low Birth Weight, Sepsis, Neonatal Sepsis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Sydney, US Agency for International Development (USAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sepsis remains a significant cause of morbidity and mortality in preterm and low birth weight (LBW) neonates, especially in low- and middle-income countries (LMICs). Lactoferrin, a glycoprotein present in breast milk with antimicrobial activity, is a low-cost, readily available, and promising intervention currently under investigation. The available literature presents conflicting results on the impact of lactoferrin on the risk of late-onset sepsis (LOS). This study evaluated the effectiveness of two doses of bovine lactoferrin (bLF) supplementation in preventing LOS and necrotizing enterocolitis (NEC) in preterm and LBW neonates in Pakistan.

Methods

A three-arm, double-blind, placebo-controlled, randomized clinical trial in the neonatal intensive care unit of Aga Khan University was conducted from July 2019 to August 2020. Preterm (28 to 36 + 5 weeks gestational age) and low birth weight (≥1000 g to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactoferrinInfant, Low Birth WeightSepsisNeonatal SepsisHumansDouble-Blind MethodInfant, NewbornFemaleAnimalsMaleCattleInfant, PrematureEnterocolitis, NecrotizingPakistanDietary SupplementsIntensive Care Units, NeonatalGestational AgeTreatment Outcome

Stichwörter der Autor:innen

lactoferrinlow birth weightpreterm newbornsepsis

Substanzen

Lactoferrin

Autor:innen und Institutionen

  • Department of Pediatric and Child Health, Aga Khan University, Karachi 74800, Pakistan.
  • Center of Excellence in Women and Child Health, Aga Khan University, Karachi 74800, Pakistan.
  • Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

ORCID-Profile: Shabina Ariff, Sajid Bashir Soofi, Arjumand Rizvi, Ashraful Alam, Michael Dibley

Förderung

  • University of Sydney
  • US Agency for International Development (USAID)

Zitieren

APA

Ariff, S., Soofi, S. B., Jiwani, U., Aamir, A., Ansari, U., Rizvi, A., D'Almeida, M., Alam, A., & Dibley, M. (2025). Evaluation of Bovine Lactoferrin for Prevention of Late-Onset Sepsis in Low-Birth-Weight Infants: A Double-Blind Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu17111774

Vancouver

Ariff S, Soofi SB, Jiwani U, Aamir A, Ansari U, Rizvi A, et al. Evaluation of Bovine Lactoferrin for Prevention of Late-Onset Sepsis in Low-Birth-Weight Infants: A Double-Blind Randomized Controlled Trial. Nutrients. 2025. doi:10.3390/nu17111774

BibTeX
@article{Ariff2025,
  author = {Ariff, Shabina and Soofi, Sajid Bashir and Jiwani, Uswa and Aamir, Almas and Ansari, Uzair and Rizvi, Arjumand and D'Almeida, Michelle and Alam, Ashraful and Dibley, Michael},
  title = {Evaluation of Bovine Lactoferrin for Prevention of Late-Onset Sepsis in Low-Birth-Weight Infants: A Double-Blind Randomized Controlled Trial},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17111774}
}
Kostenlos starten →